The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Goldman Sachs ActiveBeta® Europe Eq ETF GSEU
Morningstar’s Analysis GSEU
Will GSEU outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 3.41 | 1.6 Mil | Healthcare |
ASML Holding NV | 2.55 | 1.2 Mil | Technology |
Novartis AG Registered Shares | 1.90 | 916,105 | Healthcare |
Nestle SA | 1.82 | 877,573 | Consumer Defensive |
Roche Holding AG | 1.80 | 869,700 | Healthcare |
AstraZeneca PLC | 1.76 | 848,718 | Healthcare |
SAP SE | 1.69 | 817,739 | Technology |
Lvmh Moet Hennessy Louis Vuitton SE | 1.45 | 697,793 | Consumer Cyclical |
Shell PLC | 1.41 | 680,192 | Energy |
HSBC Holdings PLC | 1.12 | 540,002 | Financial Services |